• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(新冠病毒):分子生物化学、病理学、诊断及治疗策略的最新简要情况

SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies.

作者信息

Ismail Adel Aa

机构信息

Retired Consultant in Clinical Biochemistry and Chemical Endocrinology, West Yorkshire, UK.

出版信息

Ann Clin Biochem. 2022 Jan;59(1):59-64. doi: 10.1177/0004563221992390. Epub 2021 Feb 10.

DOI:10.1177/0004563221992390
PMID:33478237
Abstract

The ongoing coronavirus (covid-19) pandemic highlights the need for global scientific cooperation to advance our understanding of the immunological, molecular and biochemical mechanisms causing infection by this virus. Better understanding of key processes has allowed the development of vaccines in record time, and of agents with the potential to treat and neutralize current and future coronavirus outbreaks. To date, clinically effective agents for prevention and treatment of covid-19 infections are limited. This review provides a brief synopsis regarding the molecular biology, pathology and laboratory tests commonly used in the diagnosis and prognosis of covid-19, as well as the development of vaccines and therapeutic strategies to manage its current and future mutations.

摘要

持续的冠状病毒(COVID-19)大流行凸显了全球科学合作的必要性,以增进我们对该病毒感染所涉及的免疫、分子和生化机制的理解。对关键过程的更好理解使得能够在创纪录的时间内研发出疫苗,以及开发出有可能治疗和中和当前及未来冠状病毒爆发的药物。迄今为止,用于预防和治疗COVID-19感染的临床有效药物有限。本综述简要概述了COVID-19诊断和预后中常用的分子生物学、病理学及实验室检测,以及疫苗的研发和应对其当前及未来变异的治疗策略。

相似文献

1
SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies.严重急性呼吸综合征冠状病毒2(新冠病毒):分子生物化学、病理学、诊断及治疗策略的最新简要情况
Ann Clin Biochem. 2022 Jan;59(1):59-64. doi: 10.1177/0004563221992390. Epub 2021 Feb 10.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
4
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病(COVID-19)当前疫苗研发策略综述
Toxicol Pathol. 2020 Oct;48(7):800-809. doi: 10.1177/0192623320959090. Epub 2020 Sep 14.
5
Drug Discovery Strategies for SARS-CoV-2.针对 SARS-CoV-2 的药物研发策略。
J Pharmacol Exp Ther. 2020 Oct;375(1):127-138. doi: 10.1124/jpet.120.000123. Epub 2020 Jul 28.
6
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
7
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.关于在疫情爆发情况下治疗新型冠状病毒(SARS-CoV-2)的新兴治疗和预防策略的循证系统评价。
J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6):jbcpp-2020-0113. doi: 10.1515/jbcpp-2020-0113.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.微针阵列递呈的重组冠状病毒疫苗:免疫原性和快速转化开发。
EBioMedicine. 2020 May;55:102743. doi: 10.1016/j.ebiom.2020.102743. Epub 2020 Apr 2.
10
Progress in understanding COVID-19: insights from the omics approach.对 COVID-19 的认识进展:组学方法的启示。
Crit Rev Clin Lab Sci. 2021 Jun;58(4):242-252. doi: 10.1080/10408363.2020.1851167. Epub 2020 Dec 29.

引用本文的文献

1
Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.影响纳米粒子在生物医学应用中毒性的结构参数:综述
J Nanopart Res. 2023;25(3):43. doi: 10.1007/s11051-023-05690-w. Epub 2023 Feb 27.
2
Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT.基于虚拟筛选、分子动力学模拟和密度泛函理论的新型冠状病毒变异株奥密克戎受体结合域潜在抑制剂的鉴定
Front Chem. 2022 Dec 8;10:1063374. doi: 10.3389/fchem.2022.1063374. eCollection 2022.
3
Determining the Health Problems Experienced by Young Adults in Turkey, Who Received the COVID-19 Vaccine.
确定在土耳其接种了新冠疫苗的年轻人所经历的健康问题。
Vaccines (Basel). 2022 Sep 14;10(9):1526. doi: 10.3390/vaccines10091526.
4
Radiological Findings Increased the Successful of COVID-19 Diagnosis in Hospitalized Patients Suspected of Respiratory Viral Infection but with a Negative First SARS-CoV-2 RT-PCR Result.影像学检查结果提高了疑似呼吸道病毒感染但首次严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)结果为阴性的住院患者中新型冠状病毒肺炎(COVID-19)诊断的成功率。
Diagnostics (Basel). 2022 Mar 11;12(3):687. doi: 10.3390/diagnostics12030687.